Tobacco Treatment Comparison for Cancer Care
NCT06218823 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 52
Last updated 2025-10-27
Summary
This pilot comparative effectiveness trial will compare two active smoking cessation treatments in terms of effectiveness, equity across patient subpopulations, and efficiency among adult patients diagnosed with cancer within the past 3 years. An enhanced treatment comprising 12 weeks of varenicline treatment and 7 smoking cessation coaching calls with a cancer focus will be compared against an active comparator modeled after standard quitline treatments (2 weeks of nicotine patch therapy with 3 phone coaching calls). Approximately 50 participants will be recruited to generate estimates of the effects, acceptability, costs, and equity of enhanced treatment (vs. standard treatment), with the primary outcome being abstinence from smoking 26 weeks after trying to quit.
Conditions
- Smoking Cessation
- Cancer
Interventions
- DRUG
-
Transdermal Nicotine Patch
a stop smoking aid, 21 milligrams(mg), 14mg, or 7mg of nicotine delivered over 24 hours
- BEHAVIORAL
-
Standard Telephone Counseling
3 brief telephone-based smoking cessation counseling sessions
- DRUG
-
Varenicline
12 weeks of an oral smoking cessation medication
- BEHAVIORAL
-
Cancer-Targeted Telephone Counseling
7 telephone-based smoking cessation counseling sessions adapted for cancer patients
- OTHER
-
Mailed Information about Standard Care Resources
Publicly funded treatment resources including the SmokefreeTXT program sponsored by the National Cancer Institute and the Wisconsin Tobacco Quit Line.
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
University of Wisconsin, Madison
lead OTHER
Principal Investigators
-
Danielle E McCarthy, PhD · University of Wisconsin, Madison
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-01
- Primary Completion
- 2025-08-04
- Completion
- 2025-08-04
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
NCT06484179 ·Status: RECRUITING ·Phase: NA
-
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
NCT05008848 ·Status: RECRUITING ·Phase: PHASE3
-
Smoking Cessation Smartphone App for Cancer Patients (Quit2Heal Study)
NCT03600038 ·Status: COMPLETED ·Phase: NA
-
CONNECT Cancer Survivors With Tobacco Treatment
NCT07020273 ·Status: RECRUITING ·Phase: NA
-
Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies
NCT02048917 ·Status: COMPLETED ·Phase: PHASE1
-
Tobacco Use Treatment in Cancer Patients
NCT03482583 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Tobacco Quitline for Cancer Survivors
NCT00827866 ·Status: COMPLETED ·Phase: NA
-
Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
NCT01087905 ·Status: COMPLETED ·Phase: PHASE4
-
Smoking Cessation Intervention for Thoracic Patients
NCT00580398 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer
NCT01457469 ·Status: COMPLETED ·Phase: PHASE1
-
Health Systems Reach Interventions Project
NCT04199117 ·Status: COMPLETED ·Phase: PHASE4
-
Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors
NCT02233842 ·Status: COMPLETED
-
Comparative Effectiveness of Two Tobacco Cessation Interventions for Employees of Partners HealthCare, Inc.
NCT02601521 ·Status: COMPLETED ·Phase: NA
-
The Lung Screening, Tobacco and Health Project
NCT03200236 ·Status: COMPLETED ·Phase: PHASE3
-
BREATHE 2 Clinic Stop-Smoking Treatment Outreach Study
NCT05683821 ·Status: COMPLETED ·Phase: NA
-
Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult Smokers
NCT00948129 ·Status: COMPLETED ·Phase: NA
-
Evaluation of National Cancer Institute (NCI) Smoking Intervention Resources
NCT01342523 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparative Effectiveness RCT of Optimized Cessation Treatments
NCT02301403 ·Status: COMPLETED ·Phase: PHASE4
-
Cannabis and Tobacco Co-use Study
NCT04228965 ·Status: COMPLETED ·Phase: PHASE4
-
Website Smoking Cessation Intervention for the Promotion of Smoking Cessation in Low-Income Veterans
NCT04502524 ·Status: COMPLETED ·Phase: PHASE1
-
Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients
NCT07166120 ·Status: RECRUITING ·Phase: NA
-
Examining the Efficacy of a Newly Developed Smoking Cessation Program
NCT06746025 ·Status: COMPLETED
-
Feasibility, Acceptability and Fidelity of Integrating a Navigation Intervention Into Tobacco Treatment Program
NCT07072312 ·Status: COMPLETED ·Phase: NA
-
Mindfulness Based Smoking Cessation Among Cancer Survivors
NCT04038255 ·Status: TERMINATED ·Phase: PHASE4
-
Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop Smoking
NCT00021138 ·Status: COMPLETED ·Phase: NA